Yale Medicine’s Cardiomyopathy Inherited Cardiovascular Disease Program has active research investigations in three areas:
- The statistical relationship that predicts a physical trait or abnormality in a person with a given genetic mutation or a group of similar mutations.
- Prevalence and disease outcome to try and lessen the severity of disease in the four percent of patients who are recognized to have an inherited disease, whereas nearly 25 percent of patients undergoing heart transplant for end-stage cardiomyopathy have an inherited disease.
- Collaboration with the Yale Department of Genetics and the National Institutes of Health on novel gene discovery. Our aim is to help families with clear inherited disease uncover the gene mutation responsible for their family’s disease, which leads to the development of novel treatments.
Visit yalestudies.org to view available clinical trials or learn more about clinical research at Yale.